Trial NCT05338580

View at ClinicalTrials.gov 
Org. Study IDs: TJ271001STM202

Last trial update was posted on 2024-04-15

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Transitional Cell

Other Conditions

First-line Non-small-cell Lung Cancer First-line Urothelial Carcinoma Second-line Melanoma Second-line Urothelial Carcinoma

Stopping Reasons

Company Development strategy adjustment

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID